p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload

被引:767
作者
Sano, Masanori
Minamino, Tohru
Toko, Haruhiro
Miyauchi, Hideyuki
Orimo, Masayuki
Qin, Yingjie
Akazawa, Hiroshi
Tateno, Kaoru
Kayama, Yosuke
Harada, Mutsuo
Shimizu, Ippei
Asahara, Takayuki
Hamada, Hirofumi
Tomita, Shuhei
Molkentin, Jeffrey D.
Zou, Yunzeng
Komuro, Issei
机构
[1] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan
[2] RIKEN, Ctr Dev Biol, Kobe Inst Biomed Res & Innovat, Stem Cell Translat Res,Chuo Ku, Kobe, Hyogo 6500047, Japan
[3] Sapporo Med Univ, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan
[4] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan
[5] Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA
[6] Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China
[7] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China
关键词
D O I
10.1038/nature05602
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cardiac hypertrophy occurs as an adaptive response to increased workload to maintain cardiac function(1). However, prolonged cardiac hypertrophy causes heart failure(2), and its mechanisms are largely unknown. Here we show that cardiac angiogenesis is crucially involved in the adaptive mechanism of cardiac hypertrophy and that p53 accumulation is essential for the transition from cardiac hypertrophy to heart failure. Pressure overload initially promoted vascular growth in the heart by hypoxia-inducible factor-1 (Hif-1)-dependent induction of angiogenic factors, and inhibition of angiogenesis prevented the development of cardiac hypertrophy and induced systolic dysfunction. Sustained pressure overload induced an accumulation of p53 that inhibited Hif-1 activity and thereby impaired cardiac angiogenesis and systolic function. Conversely, promoting cardiac angiogenesis by introducing angiogenic factors or by inhibiting p53 accumulation developed hypertrophy further and restored cardiac dysfunction under chronic pressure overload. These results indicate that the anti-angiogenic property of p53 may have a crucial function in the transition from cardiac hypertrophy to heart failure.
引用
收藏
页码:444 / 448
页数:5
相关论文
共 24 条
[1]   p53 inhibits hypoxia-inducible factor-stimulated transcription [J].
Blagosklonny, MV ;
An, WG ;
Romanova, LY ;
Trepel, J ;
Fojo, T ;
Neckers, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :11995-11998
[2]   Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth [J].
Fei, PW ;
Wang, WG ;
Kim, SH ;
Wang, SL ;
Burns, TF ;
Sax, JK ;
Buzzai, M ;
Dicker, DT ;
McKenna, WG ;
Bernhard, EJ ;
El-Deiry, WS .
CANCER CELL, 2004, 6 (06) :597-609
[3]   Cardiac hypertrophy: The good, the bad and the ugly [J].
Frey, N ;
Olson, EN .
ANNUAL REVIEW OF PHYSIOLOGY, 2003, 65 :45-79
[4]   A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function [J].
Giordano, FJ ;
Gerber, HP ;
Williams, SP ;
VanBruggen, N ;
Bunting, S ;
Ruiz-Lozano, P ;
Gu, YS ;
Nath, AK ;
Huang, Y ;
Hickey, R ;
Dalton, N ;
Peterson, KL ;
Ross, J ;
Chien, KR ;
Ferrara, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5780-5785
[5]   Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate [J].
Goldman, CK ;
Kendall, RL ;
Cabrera, G ;
Soroceanu, L ;
Heike, Y ;
Gillespie, GY ;
Siegal, GP ;
Mao, XZ ;
Bett, AJ ;
Huckle, WR ;
Thomas, KA ;
Curiel, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8795-8800
[6]   Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors [J].
Gurova, KV ;
Hill, JE ;
Guo, CH ;
Prokvolit, A ;
Burdelya, LG ;
Samoylova, E ;
Khodyakova, AV ;
Ganapathi, R ;
Ganapathi, M ;
Tararova, ND ;
Bosykh, D ;
Lvovskiy, D ;
Webb, TR ;
Stark, GR ;
Gudkov, AV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (48) :17448-17453
[7]   G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes [J].
Harada, M ;
Qin, YJ ;
Takano, H ;
Minamino, T ;
Zou, YZ ;
Toko, H ;
Ohtsuka, M ;
Matsuura, K ;
Sano, M ;
Nishi, J ;
Iwanaga, K ;
Akazawa, H ;
Kunieda, T ;
Zhu, WD ;
Hasegawa, H ;
Kunisada, K ;
Nagai, T ;
Nakaya, H ;
Yamauchi-Takihara, K ;
Komuro, I .
NATURE MEDICINE, 2005, 11 (03) :305-311
[8]   SYNTHETIC ANALOGS OF FUMAGILLIN THAT INHIBIT ANGIOGENESIS AND SUPPRESS TUMOR-GROWTH [J].
INGBER, D ;
FUJITA, T ;
KISHIMOTO, S ;
SUDO, K ;
KANAMARU, T ;
BREM, H ;
FOLKMAN, J .
NATURE, 1990, 348 (6301) :555-557
[9]   Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1 [J].
Kelly, BD ;
Hackett, SF ;
Hirota, K ;
Oshima, Y ;
Cai, ZQ ;
Berg-Dixon, S ;
Rowan, A ;
Yan, ZJ ;
Campochiaro, PA ;
Semenza, GL .
CIRCULATION RESEARCH, 2003, 93 (11) :1074-1081
[10]   Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3 [J].
Kubasiak, LA ;
Hernandez, OM ;
Bishopric, NH ;
Webster, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :12825-12830